Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Lepu Biopharma Co. Ltd. Class H ( (HK:2157) ) just unveiled an update.
Lepu Biopharma Co., Ltd. announced the resignation of Mr. Yang Ming from his position as a supervisor due to retirement. His resignation will be effective upon the appointment of a new supervisor by the shareholders at an upcoming general meeting. The company expressed gratitude for Mr. Yang’s contributions during his tenure, and he confirmed no disagreements with the board.
The most recent analyst rating on (HK:2157) stock is a Sell with a HK$6.00 price target. To see the full list of analyst forecasts on Lepu Biopharma Co. Ltd. Class H stock, see the HK:2157 Stock Forecast page.
More about Lepu Biopharma Co. Ltd. Class H
Lepu Biopharma Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biopharmaceutical industry. The company focuses on developing and providing innovative pharmaceutical products and services.
Average Trading Volume: 21,456,538
Technical Sentiment Signal: Buy
Current Market Cap: HK$11.9B
See more data about 2157 stock on TipRanks’ Stock Analysis page.